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Abstract
Background: Adverse metabolic outcomes later in life have been reported among children or young adults who
were born as preterm infants. This study was conducted to examine the impact of very preterm/very low birth
weight (VP/VLBW) birth and subsequent growth after hospital discharge on cardiometabolic outcomes such as
insulin resistance, fasting glucose, and systolic and diastolic blood pressure (BP) among children at 6–8 years of age.
Methods: This retrospective cohort study included children aged 6–8 years and compared those who were born at
< 32 weeks of gestation or weighing < 1,500 g at birth (n = 60) with those born at term (n = 110). Body size, fat
mass, BP, glucose, insulin, leptin, adiponectin, and lipid profiles were measured. Weight-for-age z-score changes
between discharge and early school-age period were also calculated, and factors associated with BP, fasting
glucose, and insulin resistance were analyzed.
Results: Children who were born VP/VLBW had significantly lower fat masses, higher systolic BP and diastolic BP,
and significantly higher values of fasting glucose, insulin, and homeostatic model assessment of insulin resistance
(HOMA-IR), compared to children born at term. VP/VLBW was correlated with HOMA-IR and BPs after adjusting for
various factors, including fat mass index and weight-for-age z-score changes. Weight-for-age z-score changes were
associated with HOMA-IR, but not with BPs.
Conclusions: Although children aged 6–8 years who were born VP/VLBW showed significantly lower weight and
fat mass, they had significantly higher BPs, fasting glucose, HOMA-IR, and leptin levels. The associations of VP/VLBW
with cardiometabolic factors were independent of fat mass and weight gain velocity.
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Background
Prematurity accounts for almost 10 % of births world-
wide and 7.2 % of births in Korea with increasing ten-
dency [1, 2]. Despite improvements in the overall
survival of preterm infants in recent decades [3, 4],
health inequalities emerge later in life in this population.
Since the term “thrift phenomenon” was coined by
Barker and colleagues [5], an association between low
birth weight or small for gestational age (SGA) babies
and cardiometabolic problems, such as insulin resistance
and increased blood pressure (BP), has been consistently
demonstrated by many prospective and cohort studies
[6–8]. Insulin resistance plays an important role in the
development of metabolic syndrome [9].
For preterm births, the association between cardiovas-
cular diseases and metabolic syndrome in later life has
been demonstrated in several studies [10–13]. In very
preterm infants or extremely preterm infants, these car-
diometabolic changes typically begin during infancy or
school age [14–16]. A cohort study from New Zealand
reported that extreme prematurity and high body mass
index (BMI) at age 7–8 years were significant predictors
of metabolic syndrome in young adulthood [6]. Obesity
and accelerated postnatal growth during childhood were
also suggested as risk factors for adverse cardiometabolic
outcomes in children born with very low birthweight
[17]. However, it is not typical for children who were
born prematurely to be fat or obese during childhood,
even though they have cardiometabolic risks during this
period [18, 19]. So far, the association between preterm
birth and cardiometabolic risks at early school age, con-
sidering adiposity and growth velocity, has been scarcely
studied.
This study aimed to investigate whether there are dif-
ferences in the cardiometabolic factors such as insulin
resistance, fasting glucose, and systolic and diastolic BPs
in early school-aged children born prematurely com-
pared to term infants and whether these adverse cardio-




This was a retrospective cohort study evaluating children
at 6–8 years of age born as very preterm (VP) or very
low birth weight (VLBW) and term infants. Preterm in-
fants with a gestational age (GA) < 32 weeks (VP) or
birth weight < 1,500 g (VLBW) that were born between
2008 and 2009 in Seoul National University Hospital
(n = 266) were screened and the families of 136 infants
were contacted, where contact information was available.
Sixty of these consented for their children to participate
in the study. Children with congenital anomalies and
chromosomal abnormalities were excluded from the
study. There was an existing healthy children cohort op-
erated from the hospital (cohort IRB No. H 1102-097-
357) and participants in the cohort were enrolled into
the term control group, if they were born at term and
were at the age of 6–8 years during the study period.
This study was approved by the Institution of Review
Board of Seoul National University Hospital (IRB No.
H1509-030-702). The study protocol was in accordance
with the Declaration of Helsinki.
Data collection and laboratory analysis
Data on perinatal factors, including birth weight, gesta-
tional age (GA), delivery mode, and sex, were reviewed
from electronic medical records. SGA was defined as a
birth weight < 10th percentile for age according to the
latest Fenton growth charts [20]. At 6–8 years of age,
body measurements, including weight, height, and waist
circumference, were taken, and BMI was calculated
based on WHO Child Growth standards [21]. Fat mass
and fat free mass were measured using the InBody Test
(BIA; InBody 770, Biospace Co., Seoul, Korea). BP was
measured around the left upper arm using an appropri-
ately sized cuff and an automated blood pressure meas-
uring device, and the average of two blood pressure
readings was calculated. Questionnaires, completed by
the parents, were used to assess recent daily intakes of
total energy and physical activity. The self-reported BMI
of the parents was also collected at the time of
evaluation.
Blood was obtained by venipuncture after fasting for at
least 8 h. Fasting glucose, insulin, lipid profile, leptin
(Human Leptin RIA kit, LINCO Research, Inc., St.
Charles., U.S.A.), and adiponectin (Human Adiponectin
ELISA, Biovendor, Czech Republic) were measured. In-
sulin resistance was assessed using the Homeostasis
Model Assessment of Insulin Resistance (HOMA-IR),
which was calculated as the product of the fasting
plasma insulin level multiplied by the fasting plasma glu-
cose level [HOMA-IR = (fasting plasma insulin [U/mL]
× fasting plasma glucose [mg/dL])/(22.5 × 18.182)] [22].
To measure growth velocity in the study population,
the change in weight-for-age z-score between discharge
at term equivalent age from the neonatal intensive care
unit and at 6–8 years of age was taken as a variable for
VP/VLBW infants. For the term group, change in
weight-for-age z-score between birth and early school
age was calculated because preterm infants experience
postnatal growth restriction during their stay in the neo-
natal intensive care unit. The study population in each
group was further categorized according to the growth
velocity from birth in term infants or from discharge at
term equivalent age in preterm infants to 6–8 years of
age, such as those with an increase in the weight-for-age
z-scores (z-score change > 0) and those with a decrease
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in the weight-for-age z-scores (z-score change ≤ 0), for
the subgroup analysis of HOMA-IR, fasting glucose, and
systolic and diastolic BP at school age.
Statistical analysis
Data analysis was performed using STATA 12.0 for
Windows (Stata Corp, College Station, TX, USA). The
Wilcoxon rank sum test was used for the comparison of
continuous variables, and Fisher’s exact test was used for
categorical variables. HOMA-IR and leptin were skewed
and transformed onto a logarithmic scale before analysis.
Correlations between variables and cardiometabolic out-
comes such as fasting glucose, HOMR-IR, and systolic
and diastolic BP at school age were evaluated using
Pearson’s correlation coefficient and regression analyses.
Three models of partial correlation analysis were con-
ducted to measure the effect of VP/VLBW birth on car-
diometabolic outcomes. In Model I, VP/VLBW birth,
age, sex, SGA, mode of delivery, and any breast milk
feeding > 6 months were included in the multivariate re-
gression analysis for cardiometabolic outcomes. In
Model II, lean mass index (LMI) and fat mass index
(FMI) were additionally included in the multivariate ana-
lysis, and in a third model, the weight-for-age z-score
change was additionally adjusted to explore the effect of
the weight-for-age z-score change on the cardiometa-
bolic outcomes (Model III). Listwise deletion was used
to handle missing data during multiple regression ana-
lysis, which resulted in excluding the data of 31 infants
without information on breastfeeding, one infant with-
out measurement of fat mass, and one infant without
measurement of the insulin level. Sensitivity analysis was
conducted excluding SGA infants among the term and
VP/VLBW infants; the results are provided in the Sup-
plementary Materials. P-values < 0.05 were considered
statistically significant. Data are presented as the median
(interquartile range) or rates.
Results
Demographic findings of the study population
Sixty VP/VLBW and 110 term infants were included in
the study. Median GA and birth weight were 28.4 weeks
(interquartile range, 26.3–30.5 weeks) and 935 g (790-
1,220 g) in the VP/VLBW group and 39.6 weeks (38.4–
40.3 weeks) and 3,240 g (2,970-3,500 g) in the term
group (Table 1). Median postmenstrual age and weight
at discharge were 37.9 weeks (36.1–40.6 weeks) and
2,300 g (1,960-2,580 g) in the VP/VLBW infants. There
were significantly more SGA infants and Cesarean sec-
tion deliveries in the VP/VLBW group. The incidence of
breastmilk feeding at > 6 months of age was significantly
greater in the term group. There were no significant dif-
ferences in parental education level and parental BMI
between the two groups.
Body measurements at early school age
The median age at evaluation was 7.2 years (6.8–7.5
years) in the VP/VLBW group and 7.8 years (6-7.9 years)
in the term group (p = 0.801) (Table 2). The z-scores for
weight-for-age and height-for-age were significantly
lower in the VP/VLBW group. Although the BMI was
significantly lower in the VP/VLBW group (15.0 vs.
15.5 kg/m2, p = 0.003), the BMI-for-age z-scores were
comparable between the two groups (-0.5 vs. -0.3, p =
Table 1 Demographic and parental information of the study population
VP/VLBW (n = 60) Term (n = 110) p-value
GA at birth (weeks) 28.4 (26.3–30.5) 39.6 (38.4–40.3) < 0.001
Birth weight (g) 935 (790–1220) 3240 (2970–3500) < 0.001
Birth weight z-score -0.2 (-1.3-0.3) -0.2 (-0.9-0.2) 0.388
SGA 15 (25.0) 9 (8.2) 0.005
Female 28 (46.7) 57 (51.8) 0.630
Cesarean section 41 (68.3) 35 (31.8) < 0.001
PMA at discharge (weeks) 37.9 (36.1–40.6) - -
Weight at discharge (g) 2300 (1960–2580) - -
Weight-for-age z-score at discharge -1.7 (-3.3–1.0) - -
Any breastmilk feeding > 6 months 24 (46.2) 67 (77) < 0.001
Paternal education college or above 48 (80.0) 87 (79.1) 1.000
Maternal education college or above 48 (80.0) 90 (81.8) 0.838
Paternal BMI (kg/m2) 24.8 (22.1–25.9) 24.4 (22.8–26.4) 0.573
Maternal BMI (kg/m2) 21.1 (19.1–22.6) 21.5 (19.7–24) 0.146
Values are expressed as n (%) or median (interquartile range). The Wilcoxon rank sum test was used for the comparison of continuous variables, and Fisher’s exact
test was used for categorical variables
VP/VLBW very preterm/very low birthweight, GA gestational age, SGA small for gestational age, BMI body mass index, PMA postmenstrual age
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0.07). Lean body mass (18.4 vs. 19.2 kg, p = 0.18) and
lean mass index (12.6 vs. 12.9 kg/m2, p = 0.09) were also
comparable between the two groups. Fat mass (3.1 vs.
4.1 kg, p = 0.002) and fat mass index (2.1 vs. 2.8 kg/m2,
p = 0.002) were significantly lower in the VP/VLBW
group. Daily caloric intake, weekly physical activity, and
walk hours were comparable between the two groups.
Blood pressures and laboratory findings
Systolic and diastolic BPs were significantly higher in the
VP/VLBW group (107 vs. 97.5 mmHg, p < 0.001, and 64
vs. 59 mmHg, p < 001, respectively) (Table 3). In com-
parison to children born at term, children born as VP/
VLBW had significantly higher high-density lipoprotein
(HDL) cholesterol, fasting glucose, and HOMA-IR. Lep-
tin was also significantly higher in the VP/VLBW group,
while adiponectin was comparable between the two
groups.
Cardiometabolic outcomes among VP/VLBW and term
infants according to growth velocity
When VP/VLBW and term infants were further catego-
rized according to the growth pattern, VP/VLBW infants
with an increase in weight-for-age z-scores had signifi-
cantly higher HOMA-IR, fasting glucose, and systolic
and diastolic BPs than term infants with a decrease in
weight-for-age z-scores and had significantly higher fast-
ing glucose and systolic BP than term infants with an
Table 2 Body measurements in early school-aged children
VP/VLBW (n = 60) Term (n = 110) p-value
Age (years) 7.2 (6.8–7.5) 7.8 (6.0-7.9) 0.801
Weight (kg) 20.8 (19.5–24.8) 23.0 (19.9–26.9) 0.028
Weight-for-age z-score -0.8 (-1.3-0.1) 0.0 (-0.8-0.9) 0.001
Change in weight-for-age z-score 1.4 (0.2–2.8) 0.2 (-0.4-0.9) < 0.001
Height-for-age z-score -0.3 (-1.0-0.1) 0.2 (-0.2-0.9) < 0.001
BMI (kg/m2) 15.0 (13.9–15.9) 15.5 (14.6–16.9) 0.003
BMI-for-age z-score -0.5 (-1.5-0.2) -0.3 (-1-0.5) 0.072
Lean body mass (kg) 18.4 (16.9–20.2) 19.2 (17.1–21.2) 0.180
Lean mass index (kg/m2) 12.6 (12.0-13.1) 12.9 (12.3–13.4) 0.091
Fat mass (kg) 3.1 (2.1–4.1) 4.1 (2.8–5.8) 0.002
Fat mass index (kg/m2) 2.1 (1.6–2.9) 2.8 (1.9–3.9) 0.002
Waist circumference (cm) 51.6 (49.0-54.3) 53.8 (50.0–57.0) 0.013
Calorie intake (kcal/day) 1537 (1345.9-1709.4) 1441 (1299.4-1588.1) 0.114
Moderate or more activitya 120 (20–320) 180 (70–300) 0.140
Walking timea 120 (30–210) 120 (60–210) 0.403
Values are expressed as the median (interquartile range)
VP/VLBW very preterm/very low birthweight, BMI body mass index, BP blood pressure
aValues are expressed as minutes/week. The Wilcoxon rank sum test was used
Table 3 Blood pressures and laboratory findings of metabolic syndrome
VP/VLBW (n = 60) Term (n = 110) p-value
Systolic BP (mmHg) 107 (102.5–111.0) 97.5 (93.0-102.0) < 0.001
Diastolic BP (mmHg) 64 (59.3–68.5) 59 (54.5–64.0) < 0.001
HDL-Cholesterol (mg/dL) 69 (61–79) 64 (55–73) 0.010
TG (mg/dL) 60 (46–74) 57.5 (48–74) 0.844
Fasting glucose (mg/dL) 96 (93–101) 93 (88–97) < 0.001
Fasting insulin (µIU/mL) 4.4 (3.4–5.9) 3.7 (2.6–5.8) 0.053
HOMA-IR 1.1 (0.81–1.49) 0.8 (0.58–1.35) 0.017
Leptin (ng/mL) 6.4 (5.1–10.0) 5.8 (4.0-9.3) 0.040
Adiponectin (µg/mL) 9.7 (7.2–11.5) 8.9 (6.6–10.9) 0.297
Values are expressed as the median (interquartile range). The Wilcoxon rank sum test was used for the comparison of continuous variables, and Fisher’s exact test
was used for categorical variables
VP/VLBW very preterm/very low birthweight, BP blood pressure. HDL-Cholesterol high-density lipoprotein cholesterol, TG triglyceride, HOMA-IR homeostasis model
assessment of insulin resistance
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Fig. 1 Cardiometabolic outcomes of term and VP/VLBW infants according to growth pattern. VP/VLBW infants with an increase in weight-for-age
z-scores showed significantly higher fasting glucose, HOMA-IR, and systolic and diastolic BPs compared to term infants with a decrease in weight-
for-age z-scores and also showed significantly higher fasting glucose and systolic BP compared to term infants with an increase in weight-for-age
z-scores. VP/VLBW infants with a decrease in weight-for-age z-scores had a significantly higher systolic and diastolic BP than term infants with a
decrease in weight-for-age z-scores but showed no significant differences in HOMA-IR and fasting glucose compared to term infants regardless of
z-score changes. VP/VLBW very preterm/very low birthweight, HOMA-IR homeostasis model assessment of insulin resistance, BP blood pressure.
ANOVA with a Bonferroni test was conducted and *represents a significant difference between groups (P < 0.05)
Table 4 Correlation analysis for fasting glucose, HOMA-IR, and systolic and diastolic BP (Model III)
Fasting glucose HOMA-IRa Systolic BP Diastolic BP
Univariate Multivariate Univariate Multivariate Univariate Multivariate Univariate Multivariate
coef SE coef SE coef SE coef SE coef SE coef SE coef SE coef SE
VP/VLBW 3.82§ 0.98 1.88 1.39 0.28§ 0.11 0.28¶ 0.13 9.17§ 1.22 8.28§ 1.73 4.46§ 1.32 6.05§ 1.85
Age (years) 1.35¶ 0.60 0.93 0.65 0.20§ 0.06 0.17§ 0.06 2.02¶ 0.83 1.27 0.82 2.91§ 0.78 2.19¶ 0.88
Female -3.52§ 0.94 -2.56¶ 1.14 0.10 0.10 -0.03 0.11 1.48 1.34 2.04 1.43 0.43 1.30 0.29 1.53
LMI (kg/m2) 1.02 0.56 0.15 0.85 0.17§ 0.06 -0.14 0.08 0.13 0.79 -0.73 1.06 1.17 0.76 -0.08 1.14
FMI (kg/m2) 0.12 0.23 -0.46 0.34 0.13§ 0.02 0.07¶ 0.03 0.55 0.31 0.59 0.43 1.11§ 0.29 1.66§ 0.46
Weight-for-age z-score change 1.62§ 0.34 1.77§ 0.54 0.22§ 0.04 0.19§ 0.05 2.24§ 0.47 0.61 0.67 1.08¶ 0.48 -0.83 0.72
Adjusted for preterm birth, age, sex, small for gestational age, mode of delivery, lean mass index, fat mass index, any breastmilk feeding >6 months and weight-
for-age z-score change
Coef correlation coefficient, SE standard error, HOMA-IR homeostatic model assessment-insulin resistance, BP blood pressure, VP/VLBW very preterm/very low
birthweight, LMI lean mass index, BMI body mass index
aTransformed onto a logarithmic scale
¶and § represents significant correlations (p < 0.05 and p < 0.01, respectively)
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increase in weight-for-age z-scores (Fig. 1). However,
VP/VLBW infants with a decrease in weight-for-age z-
scores showed no significant differences in HOMA-IR
and fasting glucose compared to term infants regardless
of z-score changes, while systolic and diastolic BPs in
VP/VLBW infants with a decrease in z-scores were sig-
nificantly higher than in term infants with a decrease in
weight-for-age z-scores.
Among the VP/VLBW infants, fasting glucose was sig-
nificantly higher in those with an increase in weight-for-
age z-scores than in those with a decrease in weight-for-
age z-scores. In term infants, HOMA-IR and systolic
and diastolic BP were significantly higher in those with
an increase in weight-for-age z-scores than in those with
a decrease in z-scores.
Association of preterm birth and weight-for-age z-score
change with cardiometabolic outcomes
In a simple regression analysis, VP/VLBW was associ-
ated with higher systolic and diastolic BP, fasting glu-
cose, and HOMA-IR (Table 4). Partial correlation
analysis without adjusting for LMI, FMI, and weight-for-
age z-score change (Model I) showed that VP/VLBW
was associated with higher fasting glucose, HOMA-IR,
and systolic and diastolic BP (Table S1). In Model II,
which additionally adjusted for LMI and FMI, all four
outcomes were associated with VP/VLBW and FMI was
associated with HOMA-IR and diastolic BP (Table S2).
In Model III, which additionally adjusted for change in
the weight-for-age z-score as well as LMI and FMI, VP/
VLBW was associated with HOMA-IR, systolic and dia-
stolic BP (Table 4).
Weight-for-age z-score change was associated with fast-
ing glucose, HOMA-IR, and systolic and diastolic BP in
the simple regression analysis (Table 4). Multivariate ana-
lysis showed that systolic and diastolic BP were no longer
associated with the weight-for-age z-score change, while
fasting glucose and HOMA-IR remained associated with
the weight-for-age z-score change (Model III).
Regression analysis was also conducted after excluding
the SGA infants from the study population. The results
showed that VP/VLBW was also associated with systolic
and diastolic BP in both the simple regression and par-
tial correlation analysis (Table S4). Fasting glucose and
HOMA-IR were not associated with VP/VLBW in the
multivariate analysis, while weight-for-age z-score
change was significantly associated with fasting glucose
and HOMA-IR.
Discussion
In this retrospective cohort study, VP/VLBW infants
were compared with term infants for cardiometabolic
outcomes at school age, and important factors associated
with outcomes such as post-discharge growth, weight,
lean body mass, and fat mass were considered and ad-
justed. Early school-aged children who were born as VP/
VLBW had higher BP, more insulin resistance, and
higher fasting glucose than those who were term infants,
while weight and fat mass were lower in the VP/VLBW
group. Insulin resistance and BPs were consistently asso-
ciated with VP/VLBW, independent of LMI, FMI, and
weight-for-age z-score change, as shown in all three
models in the multivariate analysis. The weight-for-age
z-score change from the neonatal period to school age
was not associated with BPs but did have a significant
correlation with insulin resistance and fasting glucose in
the multivariate analysis.
Patterns of growth, as well as alterations in adipose tis-
sue, were different between SGA infants and preterm in-
fants. Previous SGA studies have reported that these
infants had less adipose tissue at birth, becoming similar
after the neonatal period [23], and a higher fat distribu-
tion was observed in childhood and adolescence [24, 25].
However, for the preterm infants, lower BMI and fat
mass were frequently seen in infancy and school age
compared with term infants [26, 27], even though they
had higher BMIs and fat mass with adverse cardiometa-
bolic outcomes in adulthood [28–31].
Although the interaction between obesity and insulin
resistance is a key pathogenesis factor in the develop-
ment of metabolic syndrome [32], cardiometabolic prob-
lems in preterm infants at school age have been
reported, despite a lower BMI during this period [15,
33]. In the present study, to elucidate the effect of body
composition more clearly, fat mass and lean body mass
were measured and adjusted, and the results showed
that preterm birth was associated with increased BP,
fasting glucose, and HOMA-IR, independent of LMI and
FMI (Models I and II).
Moreover, as catch-up growth is an important factor
in the development of insulin resistance [34], weight-for-
age z-score change until school age was considered and
adjusted, and it was found to be associated with insulin
resistance. The weight-for-age z-score was much lower
in preterm infants at discharge compared to term in-
fants, with a subsequent increase by early school age,
resulting in a higher weight gain velocity in preterm in-
fants in this study, even though the weight-for-age z-
score was still lower than that of term infants at 6–8
years of age. As with SGA infants [35, 36], preterm in-
fants experienced the development of insulin resistance
during rapid weight gain [37].
To explore the role of weight gain velocity in the de-
velopment of a cardiometabolic problem, a third multi-
variate analysis was conducted. In Model III, the weight-
for-age z-score change was additionally adjusted for and
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the results showed that preterm birth was associated
with HOMA-IR, and systolic and diastolic BP. Fasting
glucose was no longer associated with preterm birth and
the coefficient of preterm birth for HOMA-IR became
smaller than in the first two models, while the coefficient
of preterm birth for systolic and diastolic BP was similar
or higher compared with the other two models. These
interactions of the weight-for-age z-score change with
other confounding factors and cardiometabolic out-
comes suggested that glucose and insulin metabolism
could be mediated by weight gain velocity in preterm
infants.
In contrast, while higher BPs were associated with pre-
term birth in the three multivariate models, the weight-
for-age z-score change was not associated with BPs at
school age in the multivariate analysis. Although the
mechanisms of elevated BP in children born prematurely
are not fully understood, impaired development of the
glomeruli with decreased nephrons, microvascular
growth arrest, and sympathoadrenal overactivity might
be contributing factors [14, 38, 39]. These conditions
were associated with preterm birth and related morbid-
ities during a neonatal intensive care unit stay, rather
than the pattern of growth beyond the neonatal period.
However, the influence of weight gain velocity on in-
creased BP should not be ignored because a longitudinal
cohort study from the UK showed that growth gain vel-
ocity from 1 year of age until adolescence was correlated
with systolic and diastolic BP [40].
When preterm infants were further categorized ac-
cording to their growth velocity, cardiometabolic factors
were consistently higher in the preterm infants with im-
proved growth group, compared to term infants with
negative growth. However, there were no differences in
the HOMA-IR and fasting glucose levels between the
term infants with or without positive growth and the
preterm infants with negative growth, and fasting glu-
cose was lower in the preterm infant group with negative
growth than in the group with positive growth. Interest-
ingly, systolic and diastolic BPs were higher in both pre-
term infant groups, regardless of growth velocity after
discharge, than in the term infants with negative growth
and there were no differences in the systolic and dia-
stolic BPs between the two preterm groups. Notwith-
standing the small sample sizes used for these subgroup
analyses, they did demonstrate an impact of the growth
pattern in preterm infants on adverse cardiometabolic
findings, as shown in the multivariate analysis.
There are several limitations to our study. A relatively
small patient population was analyzed, and the growth
velocity of the early post-discharge period, such as the
time between discharge and 1 year of age, was not com-
pared. Also, the fat mass was not measured by dual en-
ergy X-ray absorptiometry (DEXA). However,
bioelectrical impedance analysis is a useful method for
estimating body composition and has been used in both
clinical and research fields in the pediatric population
[41, 42]. The aforementioned New Zealand Very Low
Birth Weight Study also used bioelectrical impedance as
a method to measure fat mass [6].
Conclusions
In this study, VP/VLBW was found to represent an im-
portant risk factor for elevated BP at 6–8 years, inde-
pendent of weight, fat mass, and growth velocity after
discharge. VP/VLBW, as well as growth velocity, was
also related to increased insulin resistance at 6–8 years.
Despite the low weight and low fat mass, children born
prematurely may be at a higher risk for increased BP,
and VP/VLBW infants with greater weight gain after dis-
charge may be at risk of insulin resistance during early
school age. Further studies are required to investigate
the growth pattern of VP/VLBW infants, including de-
tailed fat distribution, to determine an appropriate
growth in this population to minimize the risk of ad-
verse cardiometabolic outcomes.
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